Who is it for?
People exploring regenerative medicine for joint degeneration, sports injury recovery, skin or wellness goals, subject to diagnosis, test results and physician review.
JMedPass coordinates access to compliant regenerative medicine resources in Japan and supports eligibility discussion for stem cell, PRP and related programs. Suitability and expected benefit require physician assessment.
Book Free Assessment →Regenerative medicine is one of the most cutting-edge fields of 21st-century medicine. Its core concept: the human body possesses remarkable repair and regeneration capacity, and stem cells are the "key" to unlocking this potential.
Stem cells can differentiate into various tissue cells, continuously replenishing and repairing damaged organs. Through three infusion sessions, approximately one billion highly active stem cells are introduced into the body, producing significant effects in anti-aging, joint repair, and metabolic improvement.
Japan is one of the world's most strictly regulated and technically mature countries for regenerative medicine. All stem cell treatment institutions must hold a "Plan Number" issued by the MHLW, with strict legal constraints on culture standards, passage counts, and sterility systems.
Only institutions holding a MHLW "Plan Number" are authorized to administer stem cell infusion therapy. All JMedPass partner institutions are nationally certified, use fully serum-free media, and operate aerospace-grade sterile production systems.
From anti-aging to chronic disease improvement — precisely targeting your health needs
Intravenous infusion of highly active autologous stem cells to activate the body's cellular repair and renewal mechanisms — improving skin elasticity, energy, and sleep quality, making you feel 5+ years younger.
For ovarian insufficiency and premature ovarian failure causing hormonal imbalance and irregular menstruation, stem cells target and repair ovarian tissue to restore endocrine balance and delay female aging.
Stem cells target damaged islet β-cells to improve insulin secretion. Combined with standard medication, this effectively improves blood glucose control and reduces long-term complication risk.
Combined PRP and stem cell therapy repairs articular cartilage wear, reduces joint inflammation, relieves pain, and restores function — a non-surgical solution for knee and hip problems.
Rigorous regulation and advanced research combine to set the global treatment standard
Japan is the only country with a national "Plan Number" certification system for regenerative medicine institutions — every institution and every treatment must be approved by the MHLW.
Cell passage number is strictly limited to three generations to preserve cell activity and differentiation capacity. Fully serum-free culture media eliminates animal-derived contamination risk.
Autologous stem cells (from the patient's own fat or bone marrow) are completely compatible — no immune rejection, achieving the highest possible safety standard.
Cell culture and infusion performed entirely in Class 100 aerospace-grade sterile cleanrooms — infection risk reduced to an absolute minimum, equivalent to spacecraft component manufacturing.
Comprehensive genomic and cellular function assessment before treatment. Cell dosage, infusion frequency, and adjuvant therapies are customized to individual health status — true precision medicine.
Regular post-treatment monitoring of cell activity and health improvement indicators. JMedPass's Chinese-speaking team accompanies you throughout, ensuring ongoing professional support after you return.
From initial assessment to long-term health management — JMedPass's full Chinese support
Comprehensive evaluation to confirm suitability and set treatment goals
Japan specialist designs your personalized stem cell treatment plan
Cell collection and infusion at a certified facility, full bilingual escort
Regular health indicator tracking to evaluate therapeutic progress
JMedPass maintains contact with your Japanese physician for ongoing health support
Regenerative medicine suits people with diverse health improvement needs
Over 40, noticing changes in energy, skin or vitality, and wanting to discuss whether regenerative medicine is appropriate after physician review
Knee or hip cartilage wear, osteoarthritis — preferring regenerative repair over surgery
Type 2 diabetes, metabolic syndrome — wanting to improve metabolic function from the root cause
Premature ovarian failure, menopause symptoms, hormonal imbalance — seeking natural therapy to restore hormonal balance
Understand stem cell therapy — become an informed patient
Stem cell, PRP and related regenerative medicine programs require eligibility review by qualified medical institutions and physicians.
People exploring regenerative medicine for joint degeneration, sports injury recovery, skin or wellness goals, subject to diagnosis, test results and physician review.
Medical record screening, contraindication review, physician assessment, sampling or treatment scheduling, cell or preparation processing, treatment and follow-up observation.
Costs depend on cell source, processing method, treatment frequency, institution requirements and follow-up scope. Written quotation should follow physician plan confirmation.
Possible issues include infection, fever, pain, allergic reaction, limited response or ineligibility. It should not be described as a guaranteed cure or reversal of disease.
Frequency, duration of effect and measurable changes vary widely. Chronic disease patients should review plans with their primary doctor.
Diagnosis and symptom timeline; prior treatment records; blood tests; imaging; medication list; cancer history, immune disease history and infection history.
This page is service information only. Suitability, expected benefit and risks must be assessed by licensed physicians.